NCT01600833View on ClinicalTrials.gov

The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)

CompletedOBSERVATIONAL
Enrollment

539

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Polycystic Ovary Syndrome
Trial Locations (1)

110

WanFang Medical Center at Taipei Medical University, Taipei

All Listed Sponsors
lead

Taipei Medical University WanFang Hospital

OTHER

NCT01600833 - The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS) | Biotech Hunter | Biotech Hunter